Hjem › Graft-versus-host-sykdom › New York
Kliniske studier for Graft-versus-host-sykdom i New York
10 studier for Graft-versus-host-sykdom søker deltakere på steder i New York.
Byer i New York
Offisiell studietekst (engelsk)
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
- Roswell Park Comprehensive Cancer Center, Buffalo
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 24. aug. 2026 · NCT06450925A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
- Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- og 1 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT07359859Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT07216443A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
- Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- New York University (Data Collection Only), New York
- og 2 flere
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT07006506Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
- Northwell Health, New Hyde Park
RekruttererFase 1/2
Alder 14 til 100 · Alle kjønn · Oppdatert 29. mai 2026 · NCT05289167A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
- Memorial Sloan Kettering Cancer Center @ Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- og 1 flere
RekruttererFase 2
Alder 4 og eldre · Alle kjønn · Oppdatert 22. mai 2026 · NCT05675930A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering, New York
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 20. mai 2026 · NCT06615050Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RekruttererFase 2
Opp til 26 år · Alle kjønn · Oppdatert 14. mai 2026 · NCT07566377Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
- University of Rochester, Rochester
RekruttererFase 2
Alder 2 og eldre · Alle kjønn · Oppdatert 11. mai 2026 · NCT04380740Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 15. apr. 2025 · NCT06462365Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.